Literature DB >> 11605658

Structural and thermodynamic behavior of eukaryotic initiation factor 4E in supramolecular formation with 4E-binding protein 1 and mRNA cap analogue, studied by spectroscopic methods.

X Shen1, K Tomoo, S Uchiyama, Y Kobayashi, T Ishida.   

Abstract

The structural and thermodynamic behavior of the complex formation of eIF4E with either or both mRNA cap analogue (m7GTP, m7GpppA, or m7GpppG) and 4EBP1 has been investigated by spectroscopic measurements. Although the circular dichroism (CD) spectrum of eIF4E was little affected by the association with any cap analogue, the association constant of eIF4E with m7GpppA/G, estimated from the fluorescence quenching, was about 10 times larger than that with m7GTP. The van't Hoff analyses showed that the m7GpppA/G binding is enthalpy-driven with a large negative deltaH(o), and this is in contrast with the entropy-driven binding of m7GTP, where the positive deltaS(o) is large enough to overcome an increase of deltaH(o). This different behavior obviously originates in the interaction of the second nucleotide in m7GpppA with eIF4E, suggesting the importance of the nucleotide sequence linked to the m7Gppp terminal moiety, in addition to the specific interaction with the m7G base, for the recognition of mRNA cap structure by eIF4E. On the other hand, the CD spectra indicated that the binding of 4EBP1, an endogenous eIF4E-regulatory protein without having any defined secondary structure, shifted the m7GTP- or m7GpppA/G-bound eIF4E to an irregular structure, although such a structural change was not observed for eIF4E alone. The association constant of 4EBP1 with m7GTP- or m7GpppA/G-bound eIF4E was by two orders of magnitude larger than that with eIF4E alone. These results suggest the close interrelation in the supramolecular formation of 4EBP-eIF4E-mRNA cap structure.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11605658     DOI: 10.1248/cpb.49.1299

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  7 in total

1.  Cap-free structure of eIF4E suggests a basis for conformational regulation by its ligands.

Authors:  Laurent Volpon; Michael J Osborne; Ivan Topisirovic; Nadeem Siddiqui; Katherine L B Borden
Journal:  EMBO J       Date:  2006-10-12       Impact factor: 11.598

2.  Modified ARCA analogs providing enhanced translational properties of capped mRNAs.

Authors:  Ilona Kocmik; Karolina Piecyk; Magdalena Rudzinska; Anna Niedzwiecka; Edward Darzynkiewicz; Renata Grzela; Marzena Jankowska-Anyszka
Journal:  Cell Cycle       Date:  2018-08-17       Impact factor: 4.534

3.  Structure of the eukaryotic translation initiation factor eIF4E in complex with 4EGI-1 reveals an allosteric mechanism for dissociating eIF4G.

Authors:  Evangelos Papadopoulos; Simon Jenni; Eihab Kabha; Khuloud J Takrouri; Tingfang Yi; Nicola Salvi; Rafael E Luna; Evripidis Gavathiotis; Poornachandran Mahalingam; Haribabu Arthanari; Ricard Rodriguez-Mias; Revital Yefidoff-Freedman; Bertal H Aktas; Michael Chorev; Jose A Halperin; Gerhard Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-21       Impact factor: 11.205

4.  Structural insights into the allosteric effects of 4EBP1 on the eukaryotic translation initiation factor eIF4E.

Authors:  Nadeem Siddiqui; Wolfram Tempel; Lucy Nedyalkova; Laurent Volpon; Amy K Wernimont; Michael J Osborne; Hee-Won Park; Katherine L B Borden
Journal:  J Mol Biol       Date:  2011-12-09       Impact factor: 5.469

Review 5.  The eukaryotic translation initiation factor eIF4E in the nucleus: taking the road less traveled.

Authors:  Michael J Osborne; Katherine L B Borden
Journal:  Immunol Rev       Date:  2015-01       Impact factor: 12.988

6.  Rapamycin-insensitive mTORC1 activity controls eIF4E:4E-BP1 binding.

Authors:  Mark Livingstone; Michael Bidinosti
Journal:  F1000Res       Date:  2012-07-18

7.  Triazole-containing monophosphate mRNA cap analogs as effective translation inhibitors.

Authors:  Karolina Piecyk; Maciej Lukaszewicz; Edward Darzynkiewicz; Marzena Jankowska-Anyszka
Journal:  RNA       Date:  2014-08-22       Impact factor: 4.942

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.